Effects of Endogenous and Exogenous LL37 on the Proliferation, Migration, and Osteogenic Differentiation of BMSCs and the PI3K/Akt Signaling Pathway in Osteogenesis

Bones are not static pillars of the human body; they are living tissues that constantly repair themselves, a process driven by a special group of cells called bone marrow mesenchymal stem cells. These cells act as a versatile reserve, capable of transforming into bone, fat, or cartilage depending on what the body needs. For a broken bone to heal or for new bone to grow, these stem cells must first multiply, move to the site of injury, and then change into bone-building cells. Nature has its own tools to manage this delicate process, including a small protein called LL37. This protein, naturally produced by the body, is best known for fighting infections, but it also plays a role in tissue repair. However, the relationship between this protein and bone healing is complex. While it can help cells grow and move, too much of it can be harmful, potentially damaging the very cells it is meant to help. Understanding exactly how much is needed, and how the protein sends its instructions to the cells, is crucial for developing new ways to treat bone injuries and diseases.

Researchers set out to map this relationship in detail, testing how different amounts of LL37 affect bone marrow stem cells in a laboratory setting. They began by exposing these cells to varying concentrations of the protein to see how it influenced their ability to multiply, move, and turn into bone. The results revealed a clear pattern: the protein acts like a dimmer switch rather than a simple on-off button. At lower levels, increasing the amount of LL37 encouraged the cells to grow and move faster. However, once the concentration passed a specific point, the effect reversed. The cells stopped growing, their movement slowed, and in some cases, they began to die. The researchers found that the exact amount needed to encourage growth was different from the amount needed to encourage movement, and different again from the amount required to trigger the cells to become bone. This means the body likely uses precise, separate signals to control each step of the healing process, rather than a single blanket command.

To explore how this protein works from the inside out, the team also tried a different approach. Instead of adding the protein from the outside, they used a harmless virus to insert the gene for LL37 directly into the stem cells. This allowed the cells to produce the protein themselves, creating a steady, internal supply. They tested different strengths of this viral delivery to find the safest and most effective method. They discovered that a specific level of delivery allowed the cells to produce the protein without harming them, and these modified cells retained their ability to turn into bone or fat, proving they were still healthy and versatile. This method of getting the cells to make their own repair tool offers a potential alternative to applying the protein externally, which can be difficult to control in a living body.

The study then looked deeper into the machinery inside the cell to understand how LL37 actually tells the stem cells to become bone. By analyzing the genetic activity of the cells, the researchers identified a specific communication pathway that the protein activates. They found that LL37 turns on a chain of signals known as the PI3K/Akt pathway, which acts as a central hub for cell growth and survival. To confirm this was the key mechanism, they blocked this pathway using a chemical inhibitor. When they did this, the positive effects of LL37 disappeared; the cells no longer grew, moved, or turned into bone as effectively. This proved that the protein relies on this specific internal route to do its work. The findings suggest that whether the protein comes from outside the cell or is produced inside it, it uses the same fundamental pathway to guide bone formation.

These results clarify a long-standing debate about the role of this protein in bone healing. While some previous studies suggested it might only help indirectly, this research shows it can directly drive the stem cells to become bone, provided the concentration is just right. The study confirms that the protein is a powerful tool for regeneration, but its power is double-edged. Too little does nothing, but too much becomes toxic, disrupting the cell's structure and causing damage. The researchers concluded that the most effective strategy for future treatments would likely involve maintaining a low, steady level of the protein to guide healing without crossing the line into toxicity. By understanding these precise limits and the specific signals the protein uses, scientists can better design therapies that harness the body's natural repair mechanisms to fix broken bones and treat bone loss more effectively.